5. Литература

Поставить закладку

1. Cocco P, Piras G, Monne M, et al. Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol. 2008;87(5):148-54
2. Gisbert JP, Garcia-Buey L, Pajares JM. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: Systematic review and metaanalysis. Gastroenterology. 2003;125:1723-32
3. Сторожаков Г.И., Лепков С.В., Осканова Р.С., и соавт. Хронический вирусный гепатит С и лимфопролиферативные заболевания. Российский медицинский журнал. 2006;5:14-18
4. Idilman R, Colanntoni A, De Maria N, et al. Lymphoproliferative disorders in chronic hepatitis C. J Viral Hepat. 2004;11(4):302-9
5. Zignego AL, Giannini C, Ferri C, et al. Hepatitis C virus-related lymphoproliferative disorders:Anoverview.WorldJGastroenterol.2007;13(17):2467-78
6. Visco C, Arcaini L, Brusamolino E, et al. Distinctive natural history in hepatitis c virus positivediffuselargeB-celllymphoma:analysisof156patientsfromnorthernItaly.Ann Oncol.2006;17:1434-40
7. BessonC,CanioniD,LepageE,etal.CharacteristicsandoutcomeofdiffuselargeB-cell lymphoma in hepatitis C virus-positive in LNH 93 and LNH 98 Groupe d’Etude des Lymphomasdel’Adulteprograms.JClinOncol.2006;24:953-60
8. Tomita N, Kodama F, Takabayashi M, et al. Clinical features and outcome in HCV-positiveaggressivenon-Hodgkin’slymphoma.LeukLymph.2003;44:1159-64
9. Yang SH, Kuo SH. Reactivation of hepatitis B virus during rituximab treatment of a patientwithfollicularlymphoma.AnnHematol.2008;87(4):325-7.
10. SzynglarewiczB,MatkowskiR,SmoragZ,etal.HepatitisCvirusinfectionandlocally advancedsplenicmarginalzonelymphoma.PatholOncolRes.2007;13(4):382-4
11. GarciaM,CarranzaME.PrimaryspleniclymphomaandhepatitisBvirus.AnMedIntern. 2007;24(8):405-6
12. De Renzo A, Perna F, Persico M, et al. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non Hodgkin’s lymphoma. Eur J Haematol. 2008;4:28-34
13. VentoS,CainelliF,LonghiMS.ReactivationofreplicationofhepatitisBandCviruses after immunosuppressive therapy: an unresolved issue. The Lancet Oncology. 2002;3(6):333-340.
14. Coiffier B. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment:RoleofLamivudineprophylaxis.CancerInvest.2006;24:548-552
15. Visco C, Arcaini L, Brusamolino E, et al. Distinctive natural history inhepatitis C virus positivediffuselargeB-celllymphoma:Analysisof156patientsfromnorthernItaly.Ann Oncol.2006;17:1434-1440
16. Vento S, Cainelli F, Mirandola F, et al. Fulminant hepatitis on withdrawal of chemotherapyincarriersofhepatitisCvirus.Lancet.1996;347:92-93
17. TsutsumiY,KanamoriH,MoriA,etal.ReactivationofhepatitisBviruswithrituximab. ExpertOpinDrugSaf.2005;4:599-608
18. Aksoy S, Abali H, Kilickap S, et al. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin’s lymphoma patient. Clin Lab Haematol. 2006;28:211-214
19. EnnishiD,TeruiY,YokoyamaM,etal.MonitoringserumhepatitisCvirus(HCV)RNA in patients with HCV-infected CD20-positive B-cell lymphoma undergoing rituximab combinationchemotherapy.AmJHematol.2008;83:59-62
20. MeleA,PulsoniA,BiancoE,etal.HepatitisCvirusandB-cellnon-Hodgkinlymphomas: AnItalianmulti-centercase-controlstudy.Blood.2003;102:996-999
21. HermineO,LefrereF,BronowickiJP,etal.Regressionofspleniclymphomawithvillous lymphocytesaftertreatmentofhepatitisCvirusinfection.NEnglJMed.2002;347:89-94
22. Мухин Н.А., Абдурахманов Д.Т., Лопаткина Т.Н. Реактивация хронической HBV-инфекции: основные причины, профилактика и лечение. Практикующий врач. 2004;1:2-5
23. Абдурахманов Д.Т. Противовирусная терапия хронического гепатита В. Клиническаяфармакологияитерапия.2004;13(1):13-18
24. Лопаткина Т.Н., Абдурахманов Д.Т., Волчкова Е.В., Танащук Е.Л. Энтекавир в лечении реактивации HBV - инфекции при химиотерапии В-клеточной лимфомы. Эпидемиологияиинфекционныеболезни.Актуальныевопросы.2012;5:66-74
25. Маевская М.В., Буеверов А.О. Энтекавир - новое в лечении больных хроническим гепатитомВ.Клин.перспект.гастроэнтерол.,гепатол.2007;2:1-6
26. Ferreira R, Carvalheiro J, Torres J, et al. Fatal Hepatitis B Reactivation Treated With Entecavir in an Isolated Anti-HBs Positive Lymphoma Patient: A Case Report and LiteratureReview.TheSaudiJGastroeterol.2012;18(4):277-281
27. Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivationinpatientswithhaematologicalmalignancies.BrJHaematol.2007;136:699-712
28. Lau JY, Lai CL, Lin HJ, et al. Fatal reactivation of chronic hepatitis B virus infection followingwithdravalofchemotherapyinlymphomapatients.QJMed.1989:73:911-917
29. NiitsuN,HagiwaraY,TanaeK,etal.ProspectiveanalysisofhepatitisBvirusreactivation inpatientswithdiffuselargeB-celllymphomaafterrituximabcombinationchemotherapy. JClinOncol,2010;28:5097-5100
30. EASLClinicalPracticeGuidelines:ManagementofchronichepatitisBvirusinfection.J Hepatol.2012;57:167-185

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница